A study of the drug Seroquel XR for patients with borderline personality disorder exposes the tangled mess of interests for academics and universities involved in clinical trials for the pharmaceutical industry.
A Drug Trial’s Frayed Promise
A study of the drug Seroquel XR for patients with borderline personality disorder exposes the tangled mess of interests for academics and universities involved in clinical trials for the pharmaceutical industry.
No comments:
Post a Comment